In Re: Zetia (Ezetimibe) Antitrust Litigation
Case Number:
2:18-md-02836
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Ventker Henderson
- Faruqi & Faruqi
- Cohen Milstein
- McGuireWoods
- Kirkland & Ellis
- Wexler Boley
- Sperling & Slater
- Smith Segura
- Vanek Vickers
- Wilson Sonsini
- Girard Sharp
- Grabar Law
- Garwin Gerstein
- Kaufman & Canoles
- Williams & Connolly
- Berger Montague
- Heins Mills
- DurretteCrump
- Duncan & Allen
- Miller Shah LLP
- Goldman Ismail
- Kenny Nachwalter
- Hartley LLP
- Motley Rice
- Hangley Aronchick
- Radice Law Firm
- Lockridge Grindal
- Fisher & Phillips
- Winston & Strawn
- McDermott Will & Emery
- Willcox & Savage
- Morgan Lewis
- Zelle LLP
- Marcus & Shapira
- Hilliard & Shadowen
- BoiesBattin
- Durrette Arkema
- Boies Schiller
- The Office of Craig C. Reilly
- O'Hagan Meyer
- Nussbaum Law Group
- Gibson Dunn
- DLA Piper
- Katten Muchin
- Crenshaw Ware
- Hagens Berman
- Kessler Topaz
- Gustafson Gluek
- Glasser & Glasser
- Wolcott Rivers
- Joseph Saveri Law Firm
- Furniss Davis
- Crowell & Moring
- Taus Cebulash
- Woods Rogers
- Glancy Prongay
- Labaton Keller
- White & Case
Companies
- CVS Health Corp.
- J.M. Smith Corp.
- WellCare Health Plans Inc.
- Fraternal Order of Police
- The Kroger Co.
- H‑E‑B LP
- Wegmans Food Markets Inc.
- Glenmark Pharmaceuticals Ltd.
- Health Net Inc.
- H.D. Smith LLC
- Cencora Inc.
- Rite Aid Corp.
- Albertsons Cos. Inc.
- Mutual Drug
- Merck & Co. Inc.
- Humana Inc.
- Supervalu Inc.
- Par Pharmaceutical Cos. Inc.
- Rochester Drug Cooperative Inc.
- McKesson Corp.
- United Food & Commercial Workers International Union
- Cardinal Health Inc.
- Zydus Pharmaceuticals Inc.
- Centene Corp.
- Giant Eagle Inc.
Sectors & Industries:
-
November 02, 2018
Zetia MDL Buyers Maintain Merck's Generic Deal Was Illegal
A Virginia federal court shouldn't throw out multidistrict litigation accusing Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. of manipulating the generic drug market to keep prices of the cholesterol medication Zetia high, buyers of the drug urged, claiming they can prove antitrust violations.
-
October 12, 2018
Merck, Glenmark Tear Apart Zetia Pay-For-Delay MDL Claims
Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. have asked a Virginia federal court to throw out three complaints in multidistrict litigation accusing them of entering into an illegal reverse-payment deal to keep a generic version of the cholesterol drug Zetia off the market.
-
July 30, 2018
Lawyers Compete To Represent Zetia Buyers In Antitrust Case
More than a half-dozen law firms representing buyers of the cholesterol drug Zetia launched competing bids Friday to act as interim counsel for end payors for the drug in an antitrust MDL accusing Merck & Co. of orchestrating a pay-for-delay scheme to keep a generic version of the drug off the market.
-
July 03, 2018
Direct Drug Purchasers Aim For Consolidation In Zetia MDL
A putative class of direct purchasers of the cholesterol drug Zetia asked a Virginia federal judge on Monday to consolidate their antitrust claims accusing Merck & Co. of orchestrating a pay-for-delay scheme to keep a generic version of the drug off the market.